| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 2,131 | 2,989 | 4,168 | 6,350 | | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit | 2,131 | 2,989 | 4,168 | 6,350 | | | Operating Expenses | | Research Development | 19,320 | 20,108 | 22,976 | 22,782 | | Selling General and Administrative | 4,568 | 5,663 | 4,762 | 4,457 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (21,757) | (22,782) | (23,570) | (20,889) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (228) | (31) | (101) | 2,130 | | Earnings Before Interest And Taxes | (21,985) | (22,813) | (23,671) | (18,759) | | Interest Expense | 785 | 729 | 666 | 671 | | Income Before Tax | (22,770) | (23,542) | (24,337) | (19,430) | | Income Tax Expense | (102) |
-
|
-
|
-
| | Minority Interest | 9,772 |
-
|
-
| (16,011) | | | | Net Income From Continuing Ops | (12,896) | (23,542) | (24,337) | (15,417) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (12,896) | (23,542) | (24,337) | (15,417) | | Preferred Stock And Other Adjustments | (6,246) | 3,469 | 2,777 |
-
| | | Net Income Applicable To Common Shares | ($19,142) | ($20,073) | ($21,560) | ($15,417) |
|
0.16% Nasdaq 
0.03 (1.87%) 
Income Statement
